In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting ?-catenin, a historically "undruggable" protein, in just two months. This ...
In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide ...